Keywords
Epidemiology
Public health
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the epidemiological profile of prostate cancer in the southeastern region of Pará, for the period from 2019 to 2023. Methods: This was a cross-sectional, exploratory, descriptive study. The study population was patients who underwent or are undergoing prostate cancer treatment at UNACON - Tucuruí/PA within the period from 2019 to 2023. Results: From the analysis of the collected data, it was possible to identify the predominant age group among cancer patients, as well as information on adherence to treatment. The data analysis also allowed to identify the average time between the first consultation and the start of treatment for cancer patients, in addition to the predominant age group of these patients. The data analysis also made it possible to identify the cities in Pará with the highest frequency of prostate cancer cases. Conclusion: The analysis highlights the need for public health strategies that promote access to early diagnosis and rapid treatment, especially for more vulnerable populations, such as the elderly.
References
BENLI E, et al. Comparison of sexual behavior and inflammatory parameters in prostate cancer patients with control group: prospective controlled study. Urology Journal, 2022; 19(2): 101-105.
BERGENGREN O, et al. Update on prostate cancer epidemiology and risk factors—a systematic review. European Urology, 2023.
CIRNE F, et al. Modifiable risk factors for prostate cancer in low-and lower-middle-income countries: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 2022; 25(3): 453-462.
COUGHLIN SS, et al. A review of social determinants of prostate cancer risk, stage, and survival. Prostate International, 2020; 8(2): 49-54.
EASTHAM JA, et al. Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management. The Journal of Urology, 2022; 208(1): 10-18.
FARIA LSP, et al. Perfil epidemiológico do câncer de próstata no Brasil: retrato de uma década. Revista Uningá, 2020; 57(4): 76-84.
GRIPPA WR, et al. Análise do Câncer de Próstata na Rede de Atenção Oncológica do Espírito Santo, Brasil. Revista Brasileira de Cancerologia, 2025; 71(1).
HERBERTS C, et al. Genetic and genomic testing for prostate cancer: beyond DNA repair. American Society of Clinical Oncology Educational Book, 2023; 43: e390384.
HURWITZ LM, et al. Joint associations between established genetic susceptibility loci, pesticide exposures, and risk of prostate cancer. Environmental Research, 2023; 237: 117063.
KOTWAL AA, WALTER LC. Cancer screening among older adults: a geriatrician’s perspective on breast, cervical, colon, prostate, and lung cancer screening. Current Oncology Reports, 2020; 22: 1-12.
LABAGNARA K, et al. Low risk is low risk, regardless of race or ethnicity: outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort. Urologic Oncology: Seminars and Original Investigations, 2023; 204.e7-204.e15.
LENI R, et al. Is active surveillance an option for the management of men with low-grade prostate cancer and a positive family history? Results from a large, single-institution series. European Urology Oncology, 2023.
LOWRANCE W, et al. Updates to advanced prostate cancer: AUA/SUO guideline (2023). The Journal of Urology, 2023; 209(6): 1082-1090.
MACHADO HMB, et al. Determinantes sociais em saúde e suas implicações no processo saúde-doença da população. Revista Contemporânea, 2023; 3(6): 6086-6102.
MAXWELL KN, et al. Inherited TP53 variants and risk of prostate cancer. European Urology, 2022; 81(3): 243-250.
MERRIEL SWD. Prostate cancer in primary care. Advances in Therapy, 2018; 35(9): 1285-1294.
NG CT, et al. Approaches to prevent and manage cardiovascular disease in patients receiving therapy for prostate cancer. Current Cardiology Reports, 2023; 1-11.
PEREIRA KG, et al. Fatores associados à masculinidade no diagnóstico precoce do câncer de próstata: revisão narrativa. Revista Nursing, 2021; 24(277): 5803-5810.
PONTE JP, et al. Tratamento do câncer de próstata, hormônio refratário atual e suas inovações: revisão de literatura. Brazilian Journal of Health Review, 2021; 4(2): 6924-6930.
SANTOS MO, et al. Estimativa de incidência de câncer no Brasil, 2023-2025. Revista Brasileira de Cancerologia, 2023; 69(1).